Nasdaq · CIK 0001948455
ISPR Ispire Technology Inc.
Insider trading from SEC Form 4. Last filing Mar 19, 2026. Close $1.52 on Oct 9, 2026, +38% from the 52-week low and -59% from the high.
Ispire Technology Inc. (ISPR) has 19 SEC Form 4 filings on file from 5 insiders, the latest filed on Mar 19, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
7 open-market trades have been scored at ISPR. The newest: Michael Xue Wang (Co-Chief Executive Officer) bought $12k of stock on Feb 27, 2026, filed Mar 2, 2026, scored 38 (weak). The largest of the 7 shown: Steven P. Pryzbyla (CLO and Secretary) sold $45k on Sep 26, 2025, scored 21 (weak).
ISPR closed at $1.52 on Oct 9, 2026, 38% above its 52-week low and 59% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Ispire Technology Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Michael Xue Wang Co-Chief Executive Officer buy | $12k 5,000 shares | +1% | +57% from low-51% from high | |
| 33Weak | Michael Xue Wang Co-Chief Executive Officer buy | $19k 8,000 shares | +2% | +42% from low-56% from high | |
| 20Weak | Steven P. Pryzbyla CLO and Secretary sell | $30k 9,000 shares | -2% | +120% from low-32% from high | |
| 20Weak | John Fargis director sell | $15k 7,500 shares | -16% | +24% from low-71% from high | |
| 21Weak | Steven P. Pryzbyla CLO and Secretary sell | $45k 17,046 shares | -4% | +25% from low-62% from high | |
| 15Weak | Steven P. Pryzbyla CLO and Secretary sell | $1,785 500 shares | -0% | - | |
| 15Weak | Steven P. Pryzbyla CLO and Secretary sell | $25k 6,200 shares | -1% | - |
Transactions
Every row filed, 33 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 19, 2026 | Brent Cox director | AGrant or award Common Stock | +35,526 | $0.00 | $0 | 86,308 | Mar 19, 2026 |
| Mar 19, 2026 | John Fargis director | AGrant or award Common Stock | +35,526 | $0.00 | $0 | 74,625 | Mar 19, 2026 |
| Mar 19, 2026 | Christopher Robert Burch director | AGrant or award Common Stock | +35,526 | $0.00 | $0 | 77,184 | Mar 19, 2026 |
| Feb 27, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +984 | $2.38 | $2,342 | 462,866 | Mar 2, 2026 |
| Feb 27, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +100 | $2.39 | $239 | 462,966 | Mar 2, 2026 |
| Feb 27, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +916 | $2.44 | $2,234 | 463,882 | Mar 2, 2026 |
| Mar 2, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +100 | $2.38 | $238 | 463,982 | Mar 2, 2026 |
| Mar 2, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +1,163 | $2.41 | $2,798 | 465,145 | Mar 2, 2026 |
| Mar 2, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +1,737 | $2.37 | $4,108 | 466,882 | Mar 2, 2026 |
| Feb 24, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +959 | $2.21 | $2,118 | 454,841 | Feb 26, 2026 |
| Feb 24, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +1,041 | $2.21 | $2,295 | 455,882 | Feb 26, 2026 |
| Feb 25, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +1,084 | $2.34 | $2,537 | 456,966 | Feb 26, 2026 |
| Feb 25, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +916 | $2.36 | $2,162 | 457,882 | Feb 26, 2026 |
| Feb 25, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +2,000 | $2.30 | $4,609 | 459,882 | Feb 26, 2026 |
| Feb 26, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +1,900 | $2.41 | $4,570 | 461,782 | Feb 26, 2026 |
| Feb 26, 2026 | Michael Xue Wang Co-Chief Executive Officer | POpen-market purchase Common Stock | +100 | $2.39 | $239 | 461,882 | Feb 26, 2026 |
| Feb 12, 2026 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -3,000 | $3.41 | $10k | 396,664 | Feb 17, 2026 |
| Feb 13, 2026 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -3,000 | $3.23 | $9,697 | 393,664 | Feb 17, 2026 |
| Feb 17, 2026 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -3,000 | $3.22 | $9,670 | 390,664 | Feb 17, 2026 |
| Nov 20, 2025 | John Fargis director | SOpen-market sale Common Stock | -7,500 | $1.95 | $15k | 39,099 | Nov 24, 2025 |
| Sep 26, 2025 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -17,046 | $2.64 | $45k | 399,664 | Oct 2, 2025 |
| Jul 10, 2025 | Christopher Robert Burch director | AGrant or award Common Stock | +27,178 | $0.00 | $0 | 41,658 | Jul 11, 2025 |
| Jul 10, 2025 | Brent Cox director | AGrant or award Common Stock | +29,784 | $0.00 | $0 | 50,782 | Jul 11, 2025 |
| Jul 10, 2025 | John Fargis director | AGrant or award Common Stock | +27,178 | $0.00 | $0 | 46,599 | Jul 11, 2025 |
| Mar 17, 2025 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -500 | $3.57 | $1,785 | 416,710 | Mar 19, 2025 |
| Mar 12, 2025 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -61 | $4.00 | $244 | 423,349 | Mar 14, 2025 |
| Mar 13, 2025 | Steven P. Pryzbyla CLO and Secretary | SOpen-market sale Common Stock | -6,139 | $4.03 | $25k | 417,210 | Mar 14, 2025 |
| Jan 7, 2025 | Christopher Robert Burch director | AGrant or award Common Stock | +7,370 | $0.00 | $0 | 14,480 | Jan 10, 2025 |
| Jan 7, 2025 | Brent Cox director | AGrant or award Common Stock | +8,077 | $0.00 | $0 | 20,998 | Jan 10, 2025 |
| Jan 7, 2025 | John Fargis director | AGrant or award Common Stock | +7,370 | $0.00 | $0 | 19,421 | Jan 10, 2025 |
| Oct 17, 2024 | Christopher Robert Burch director | AGrant or award Common Stock | +1,685 | $0.00 | $0 | 7,110 | Oct 17, 2024 |
| Oct 17, 2024 | Brent Cox director | AGrant or award Common Stock | +2,107 | $0.00 | $0 | 12,921 | Oct 17, 2024 |
| Oct 17, 2024 | John Fargis director | AGrant or award Common Stock | +1,685 | $0.00 | $0 | 12,051 | Oct 17, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Christopher Robert Burchdirector
- Brent Coxdirector
- John Fargisdirector
- Steven P. PryzbylaCLO and Secretary
- Michael Xue WangCo-Chief Executive Officer
Questions about ISPR
Answered from the filings on this page, as of the latest one.
Are insiders buying ISPR?
No. In the last 90 days no insider at Ispire Technology Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade ISPR on the open market?
Michael Xue Wang (Co-Chief Executive Officer) bought $12k of ISPR on Feb 27, 2026 and filed the Form 4 on Mar 2, 2026. InsiderTell scored 38 (weak).
How many insiders file Form 4 at Ispire Technology Inc.?
5 people have filed a Form 4 at Ispire Technology Inc., among them Christopher Robert Burch (director), Brent Cox (director), John Fargis (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.